Immunization of the population through vaccination against COVID-19 is
recognized as a public health priority. The most difficult scientific
challenge for vaccines is the clinical safety and efficacy. We report a
patient presenting with Fusobacterium nucleatum bacteremia and liver
abscess formation following administration of anti-COVID-19
viral-vectored vaccine.